Download PDF
1 / Pages

Other users also viewed these articles

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment Javier Narváez; Petra Díaz del Campo Fontecha; Noé Brito García; Gema Bonilla; Myriam Aburto; Iván Castellví; Esteban Cano-Jiménez; Natalia Mena-Vázquez; M. Asunción Nieto; Ana María Ortiz; Claudia Valenzuela; Miguel Ángel Abad Hernández; Isabel Castrejón; María Correyero Plaza; Félix Manuel Francisco Hernández; María Vanesa Hernández Hernández; José Antonio Rodríquez Portal;
Reumatol Clin. 2022;18:501-12
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis José Antonio Rodríguez Portal; Noé Brito García; Petra Díaz del Campo Fontecha; Claudia Valenzuela; Ana María Ortiz; M. Asunción Nieto; Natalia Mena-Vázquez; Esteban Cano-Jiménez; Iván Castellví; Myriam Aburto; Gema Bonilla; María Vanesa Hernández Hernández; Félix Manuel Francisco Hernández; María Correyero Plaza; Isabel Castrejón; Miguel Ángel Abad Hernández; Javier Narváez;
Reumatol Clin. 2022;18:443-52
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48